nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C9—brain cancer	0.829	1	CbGaD
Nilutamide—POR—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00447	0.104	CbGpPWpGaD
Nilutamide—Enzalutamide—CYP2C9—brain cancer	0.00363	1	CrCbGaD
Nilutamide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00266	0.0619	CbGpPWpGaD
Nilutamide—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00239	0.0556	CbGpPWpGaD
Nilutamide—Interstitial pneumonia—Temozolomide—brain cancer	0.00233	0.0187	CcSEcCtD
Nilutamide—Visual disturbance—Lomustine—brain cancer	0.00225	0.0181	CcSEcCtD
Nilutamide—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00217	0.0506	CbGpPWpGaD
Nilutamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00213	0.0496	CbGpPWpGaD
Nilutamide—Nocturia—Procarbazine—brain cancer	0.00201	0.0161	CcSEcCtD
Nilutamide—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.00196	0.0457	CbGpPWpGaD
Nilutamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00194	0.0452	CbGpPWpGaD
Nilutamide—Interstitial pneumonia—Etoposide—brain cancer	0.00187	0.015	CcSEcCtD
Nilutamide—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00185	0.0431	CbGpPWpGaD
Nilutamide—Melaena—Procarbazine—brain cancer	0.00182	0.0146	CcSEcCtD
Nilutamide—Photophobia—Procarbazine—brain cancer	0.00175	0.0141	CcSEcCtD
Nilutamide—Gynaecomastia—Procarbazine—brain cancer	0.00167	0.0134	CcSEcCtD
Nilutamide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00165	0.0385	CbGpPWpGaD
Nilutamide—Interstitial lung disease—Carmustine—brain cancer	0.00165	0.0132	CcSEcCtD
Nilutamide—Interstitial lung disease—Temozolomide—brain cancer	0.00159	0.0128	CcSEcCtD
Nilutamide—Lung disorder—Temozolomide—brain cancer	0.00159	0.0128	CcSEcCtD
Nilutamide—Creatinine increased—Hydroxyurea—brain cancer	0.00152	0.0122	CcSEcCtD
Nilutamide—Visual impairment—Lomustine—brain cancer	0.00142	0.0114	CcSEcCtD
Nilutamide—Blood urea increased—Hydroxyurea—brain cancer	0.00136	0.0109	CcSEcCtD
Nilutamide—Alopecia—Lomustine—brain cancer	0.0013	0.0105	CcSEcCtD
Nilutamide—Interstitial lung disease—Etoposide—brain cancer	0.00128	0.0102	CcSEcCtD
Nilutamide—Leukopenia—Lomustine—brain cancer	0.00115	0.00923	CcSEcCtD
Nilutamide—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00115	0.0267	CbGpPWpGaD
Nilutamide—Angina pectoris—Procarbazine—brain cancer	0.00114	0.00915	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00113	0.00905	CcSEcCtD
Nilutamide—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.0011	0.0257	CbGpPWpGaD
Nilutamide—Pneumonia—Procarbazine—brain cancer	0.00105	0.00842	CcSEcCtD
Nilutamide—Gynaecomastia—Carmustine—brain cancer	0.00104	0.00838	CcSEcCtD
Nilutamide—Pain—Carboplatin—brain cancer	0.00103	0.00822	CcSEcCtD
Nilutamide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00102	0.0239	CbGpPWpGaD
Nilutamide—Abnormal vision—Carmustine—brain cancer	0.00102	0.00817	CcSEcCtD
Nilutamide—Sweating—Procarbazine—brain cancer	0.001	0.00803	CcSEcCtD
Nilutamide—Anorexia—Lomustine—brain cancer	0.001	0.00802	CcSEcCtD
Nilutamide—Haematuria—Procarbazine—brain cancer	0.000996	0.00798	CcSEcCtD
Nilutamide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000984	0.0229	CbGpPWpGaD
Nilutamide—Abnormal vision—Temozolomide—brain cancer	0.000984	0.00789	CcSEcCtD
Nilutamide—Blood creatinine increased—Hydroxyurea—brain cancer	0.000982	0.00788	CcSEcCtD
Nilutamide—Body temperature increased—Carboplatin—brain cancer	0.000948	0.0076	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.000942	0.00755	CcSEcCtD
Nilutamide—Decreased appetite—Lomustine—brain cancer	0.000912	0.00731	CcSEcCtD
Nilutamide—Phosphatase alkaline increased—Etoposide—brain cancer	0.000903	0.00724	CcSEcCtD
Nilutamide—Hot flush—Temozolomide—brain cancer	0.000876	0.00702	CcSEcCtD
Nilutamide—Menopausal symptoms—Temozolomide—brain cancer	0.000868	0.00696	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.000858	0.02	CbGpPWpGaD
Nilutamide—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000848	0.0068	CcSEcCtD
Nilutamide—Body temperature increased—Lomustine—brain cancer	0.000829	0.00665	CcSEcCtD
Nilutamide—Alopecia—Procarbazine—brain cancer	0.000828	0.00664	CcSEcCtD
Nilutamide—Tension—Procarbazine—brain cancer	0.000801	0.00642	CcSEcCtD
Nilutamide—Nervousness—Procarbazine—brain cancer	0.000792	0.00636	CcSEcCtD
Nilutamide—Anaemia—Procarbazine—brain cancer	0.000754	0.00605	CcSEcCtD
Nilutamide—AR—FOXA1 transcription factor network—SHH—brain cancer	0.000754	0.0176	CbGpPWpGaD
Nilutamide—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000754	0.00604	CcSEcCtD
Nilutamide—Dry skin—Temozolomide—brain cancer	0.000751	0.00602	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000738	0.00592	CcSEcCtD
Nilutamide—Syncope—Procarbazine—brain cancer	0.000732	0.00587	CcSEcCtD
Nilutamide—Leukopenia—Procarbazine—brain cancer	0.00073	0.00586	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000722	0.00579	CcSEcCtD
Nilutamide—Loss of consciousness—Procarbazine—brain cancer	0.000717	0.00575	CcSEcCtD
Nilutamide—Cough—Procarbazine—brain cancer	0.000712	0.00571	CcSEcCtD
Nilutamide—Hypertension—Procarbazine—brain cancer	0.000704	0.00565	CcSEcCtD
Nilutamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000703	0.0164	CbGpPWpGaD
Nilutamide—Dry mouth—Procarbazine—brain cancer	0.000679	0.00545	CcSEcCtD
Nilutamide—AR—Nuclear Receptors—ESR2—brain cancer	0.000678	0.0158	CbGpPWpGaD
Nilutamide—Cardiac failure—Etoposide—brain cancer	0.000672	0.00539	CcSEcCtD
Nilutamide—Vomiting—Lomustine—brain cancer	0.000667	0.00535	CcSEcCtD
Nilutamide—Oedema—Procarbazine—brain cancer	0.000666	0.00534	CcSEcCtD
Nilutamide—Hyperglycaemia—Carmustine—brain cancer	0.000661	0.0053	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Temozolomide—brain cancer	0.000658	0.00528	CcSEcCtD
Nilutamide—Pneumonia—Carmustine—brain cancer	0.000657	0.00527	CcSEcCtD
Nilutamide—Shock—Procarbazine—brain cancer	0.000655	0.00525	CcSEcCtD
Nilutamide—Erectile dysfunction—Temozolomide—brain cancer	0.000652	0.00523	CcSEcCtD
Nilutamide—Depression—Carmustine—brain cancer	0.000651	0.00522	CcSEcCtD
Nilutamide—Hyperhidrosis—Procarbazine—brain cancer	0.000644	0.00516	CcSEcCtD
Nilutamide—Alopecia—Hydroxyurea—brain cancer	0.000641	0.00514	CcSEcCtD
Nilutamide—Weight decreased—Temozolomide—brain cancer	0.000641	0.00514	CcSEcCtD
Nilutamide—Hyperglycaemia—Temozolomide—brain cancer	0.000639	0.00512	CcSEcCtD
Nilutamide—Urinary tract infection—Carmustine—brain cancer	0.000635	0.00509	CcSEcCtD
Nilutamide—Pneumonia—Temozolomide—brain cancer	0.000635	0.00509	CcSEcCtD
Nilutamide—Anorexia—Procarbazine—brain cancer	0.000635	0.00509	CcSEcCtD
Nilutamide—Depression—Temozolomide—brain cancer	0.000629	0.00505	CcSEcCtD
Nilutamide—Nausea—Lomustine—brain cancer	0.000623	0.005	CcSEcCtD
Nilutamide—Urinary tract infection—Temozolomide—brain cancer	0.000614	0.00492	CcSEcCtD
Nilutamide—Insomnia—Procarbazine—brain cancer	0.000602	0.00483	CcSEcCtD
Nilutamide—Paraesthesia—Procarbazine—brain cancer	0.000598	0.0048	CcSEcCtD
Nilutamide—Ill-defined disorder—Hydroxyurea—brain cancer	0.000586	0.0047	CcSEcCtD
Nilutamide—Anaemia—Hydroxyurea—brain cancer	0.000584	0.00468	CcSEcCtD
Nilutamide—Hypoaesthesia—Carmustine—brain cancer	0.000583	0.00468	CcSEcCtD
Nilutamide—Decreased appetite—Procarbazine—brain cancer	0.000579	0.00464	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Etoposide—brain cancer	0.000578	0.00464	CcSEcCtD
Nilutamide—Oedema peripheral—Carmustine—brain cancer	0.000578	0.00463	CcSEcCtD
Nilutamide—Malaise—Hydroxyurea—brain cancer	0.000569	0.00457	CcSEcCtD
Nilutamide—Constipation—Procarbazine—brain cancer	0.000569	0.00457	CcSEcCtD
Nilutamide—Pain—Procarbazine—brain cancer	0.000569	0.00457	CcSEcCtD
Nilutamide—Leukopenia—Hydroxyurea—brain cancer	0.000565	0.00453	CcSEcCtD
Nilutamide—Visual impairment—Carmustine—brain cancer	0.000565	0.00453	CcSEcCtD
Nilutamide—Hypoaesthesia—Temozolomide—brain cancer	0.000564	0.00452	CcSEcCtD
Nilutamide—Urinary tract disorder—Temozolomide—brain cancer	0.00056	0.00449	CcSEcCtD
Nilutamide—Oedema peripheral—Temozolomide—brain cancer	0.000558	0.00448	CcSEcCtD
Nilutamide—Urethral disorder—Temozolomide—brain cancer	0.000556	0.00446	CcSEcCtD
Nilutamide—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000551	0.0128	CbGpPWpGaD
Nilutamide—Feeling abnormal—Procarbazine—brain cancer	0.000549	0.0044	CcSEcCtD
Nilutamide—Visual impairment—Temozolomide—brain cancer	0.000546	0.00438	CcSEcCtD
Nilutamide—Gastrointestinal pain—Procarbazine—brain cancer	0.000545	0.00437	CcSEcCtD
Nilutamide—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000536	0.0125	CbGpPWpGaD
Nilutamide—Discomfort—Hydroxyurea—brain cancer	0.000531	0.00426	CcSEcCtD
Nilutamide—Abdominal pain—Procarbazine—brain cancer	0.000526	0.00422	CcSEcCtD
Nilutamide—Body temperature increased—Procarbazine—brain cancer	0.000526	0.00422	CcSEcCtD
Nilutamide—Alopecia—Carmustine—brain cancer	0.000518	0.00416	CcSEcCtD
Nilutamide—Oedema—Hydroxyurea—brain cancer	0.000515	0.00413	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.000515	0.012	CbGpPWpGaD
Nilutamide—Pneumonia—Etoposide—brain cancer	0.000508	0.00407	CcSEcCtD
Nilutamide—Alopecia—Temozolomide—brain cancer	0.000501	0.00402	CcSEcCtD
Nilutamide—Back pain—Carmustine—brain cancer	0.000494	0.00396	CcSEcCtD
Nilutamide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000492	0.0115	CbGpPWpGaD
Nilutamide—Anorexia—Hydroxyurea—brain cancer	0.000491	0.00394	CcSEcCtD
Nilutamide—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.000491	0.0114	CbGpPWpGaD
Nilutamide—Asthenia—Procarbazine—brain cancer	0.000478	0.00383	CcSEcCtD
Nilutamide—Back pain—Temozolomide—brain cancer	0.000477	0.00383	CcSEcCtD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000476	0.0111	CbGpPWpGaD
Nilutamide—Anaemia—Carmustine—brain cancer	0.000472	0.00378	CcSEcCtD
Nilutamide—Pruritus—Procarbazine—brain cancer	0.000471	0.00378	CcSEcCtD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00047	0.011	CbGpPWpGaD
Nilutamide—Dyspnoea—Hydroxyurea—brain cancer	0.000459	0.00369	CcSEcCtD
Nilutamide—Ill-defined disorder—Temozolomide—brain cancer	0.000458	0.00367	CcSEcCtD
Nilutamide—Leukopenia—Carmustine—brain cancer	0.000457	0.00366	CcSEcCtD
Nilutamide—Anaemia—Temozolomide—brain cancer	0.000456	0.00366	CcSEcCtD
Nilutamide—Diarrhoea—Procarbazine—brain cancer	0.000456	0.00365	CcSEcCtD
Nilutamide—Dyspepsia—Hydroxyurea—brain cancer	0.000454	0.00364	CcSEcCtD
Nilutamide—Hypoaesthesia—Etoposide—brain cancer	0.000451	0.00362	CcSEcCtD
Nilutamide—Decreased appetite—Hydroxyurea—brain cancer	0.000448	0.00359	CcSEcCtD
Nilutamide—Urinary tract disorder—Etoposide—brain cancer	0.000448	0.00359	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000445	0.00357	CcSEcCtD
Nilutamide—Malaise—Temozolomide—brain cancer	0.000445	0.00357	CcSEcCtD
Nilutamide—Urethral disorder—Etoposide—brain cancer	0.000445	0.00357	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000444	0.0104	CbGpPWpGaD
Nilutamide—Leukopenia—Temozolomide—brain cancer	0.000442	0.00354	CcSEcCtD
Nilutamide—Hypertension—Carmustine—brain cancer	0.000441	0.00353	CcSEcCtD
Nilutamide—Constipation—Hydroxyurea—brain cancer	0.000441	0.00353	CcSEcCtD
Nilutamide—Pain—Hydroxyurea—brain cancer	0.000441	0.00353	CcSEcCtD
Nilutamide—Dizziness—Procarbazine—brain cancer	0.00044	0.00353	CcSEcCtD
Nilutamide—Chest pain—Carmustine—brain cancer	0.000435	0.00349	CcSEcCtD
Nilutamide—Cough—Temozolomide—brain cancer	0.00043	0.00345	CcSEcCtD
Nilutamide—Hypertension—Temozolomide—brain cancer	0.000426	0.00342	CcSEcCtD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000425	0.0099	CbGpPWpGaD
Nilutamide—Feeling abnormal—Hydroxyurea—brain cancer	0.000425	0.00341	CcSEcCtD
Nilutamide—Vomiting—Procarbazine—brain cancer	0.000423	0.0034	CcSEcCtD
Nilutamide—Rash—Procarbazine—brain cancer	0.00042	0.00337	CcSEcCtD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000419	0.00977	CbGpPWpGaD
Nilutamide—Dermatitis—Procarbazine—brain cancer	0.000419	0.00336	CcSEcCtD
Nilutamide—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000419	0.00976	CbGpPWpGaD
Nilutamide—Headache—Procarbazine—brain cancer	0.000417	0.00335	CcSEcCtD
Nilutamide—Oedema—Carmustine—brain cancer	0.000417	0.00334	CcSEcCtD
Nilutamide—Discomfort—Temozolomide—brain cancer	0.000415	0.00333	CcSEcCtD
Nilutamide—Dry mouth—Temozolomide—brain cancer	0.000411	0.00329	CcSEcCtD
Nilutamide—Body temperature increased—Hydroxyurea—brain cancer	0.000407	0.00327	CcSEcCtD
Nilutamide—Oedema—Temozolomide—brain cancer	0.000403	0.00323	CcSEcCtD
Nilutamide—Alopecia—Etoposide—brain cancer	0.000401	0.00321	CcSEcCtD
Nilutamide—Anorexia—Carmustine—brain cancer	0.000397	0.00319	CcSEcCtD
Nilutamide—Nausea—Procarbazine—brain cancer	0.000396	0.00317	CcSEcCtD
Nilutamide—Hyperhidrosis—Temozolomide—brain cancer	0.000389	0.00312	CcSEcCtD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000386	0.009	CbGpPWpGaD
Nilutamide—Anorexia—Temozolomide—brain cancer	0.000384	0.00308	CcSEcCtD
Nilutamide—Back pain—Etoposide—brain cancer	0.000382	0.00306	CcSEcCtD
Nilutamide—Insomnia—Carmustine—brain cancer	0.000377	0.00302	CcSEcCtD
Nilutamide—Paraesthesia—Carmustine—brain cancer	0.000374	0.003	CcSEcCtD
Nilutamide—Dyspnoea—Carmustine—brain cancer	0.000371	0.00298	CcSEcCtD
Nilutamide—Asthenia—Hydroxyurea—brain cancer	0.00037	0.00297	CcSEcCtD
Nilutamide—Ill-defined disorder—Etoposide—brain cancer	0.000366	0.00294	CcSEcCtD
Nilutamide—Anaemia—Etoposide—brain cancer	0.000365	0.00293	CcSEcCtD
Nilutamide—Insomnia—Temozolomide—brain cancer	0.000364	0.00292	CcSEcCtD
Nilutamide—Decreased appetite—Carmustine—brain cancer	0.000362	0.0029	CcSEcCtD
Nilutamide—Paraesthesia—Temozolomide—brain cancer	0.000362	0.0029	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Carmustine—brain cancer	0.00036	0.00288	CcSEcCtD
Nilutamide—Dyspnoea—Temozolomide—brain cancer	0.000359	0.00288	CcSEcCtD
Nilutamide—Pain—Carmustine—brain cancer	0.000356	0.00286	CcSEcCtD
Nilutamide—Constipation—Carmustine—brain cancer	0.000356	0.00286	CcSEcCtD
Nilutamide—Malaise—Etoposide—brain cancer	0.000356	0.00286	CcSEcCtD
Nilutamide—Dyspepsia—Temozolomide—brain cancer	0.000354	0.00284	CcSEcCtD
Nilutamide—Leukopenia—Etoposide—brain cancer	0.000353	0.00283	CcSEcCtD
Nilutamide—Diarrhoea—Hydroxyurea—brain cancer	0.000353	0.00283	CcSEcCtD
Nilutamide—Decreased appetite—Temozolomide—brain cancer	0.00035	0.00281	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000348	0.00279	CcSEcCtD
Nilutamide—Loss of consciousness—Etoposide—brain cancer	0.000347	0.00278	CcSEcCtD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000345	0.00803	CbGpPWpGaD
Nilutamide—Cough—Etoposide—brain cancer	0.000344	0.00276	CcSEcCtD
Nilutamide—Pain—Temozolomide—brain cancer	0.000344	0.00276	CcSEcCtD
Nilutamide—Constipation—Temozolomide—brain cancer	0.000344	0.00276	CcSEcCtD
Nilutamide—Feeling abnormal—Carmustine—brain cancer	0.000343	0.00275	CcSEcCtD
Nilutamide—Hypertension—Etoposide—brain cancer	0.000341	0.00273	CcSEcCtD
Nilutamide—Dizziness—Hydroxyurea—brain cancer	0.000341	0.00273	CcSEcCtD
Nilutamide—Gastrointestinal pain—Carmustine—brain cancer	0.000341	0.00273	CcSEcCtD
Nilutamide—Chest pain—Etoposide—brain cancer	0.000336	0.0027	CcSEcCtD
Nilutamide—Discomfort—Etoposide—brain cancer	0.000332	0.00266	CcSEcCtD
Nilutamide—Feeling abnormal—Temozolomide—brain cancer	0.000332	0.00266	CcSEcCtD
Nilutamide—Abdominal pain—Carmustine—brain cancer	0.000329	0.00264	CcSEcCtD
Nilutamide—Body temperature increased—Carmustine—brain cancer	0.000329	0.00264	CcSEcCtD
Nilutamide—Gastrointestinal pain—Temozolomide—brain cancer	0.000329	0.00264	CcSEcCtD
Nilutamide—Vomiting—Hydroxyurea—brain cancer	0.000328	0.00263	CcSEcCtD
Nilutamide—Rash—Hydroxyurea—brain cancer	0.000325	0.00261	CcSEcCtD
Nilutamide—Dermatitis—Hydroxyurea—brain cancer	0.000325	0.0026	CcSEcCtD
Nilutamide—Headache—Hydroxyurea—brain cancer	0.000323	0.00259	CcSEcCtD
Nilutamide—Abdominal pain—Temozolomide—brain cancer	0.000318	0.00255	CcSEcCtD
Nilutamide—Body temperature increased—Temozolomide—brain cancer	0.000318	0.00255	CcSEcCtD
Nilutamide—Hyperhidrosis—Etoposide—brain cancer	0.000311	0.0025	CcSEcCtD
Nilutamide—Anorexia—Etoposide—brain cancer	0.000307	0.00246	CcSEcCtD
Nilutamide—Nausea—Hydroxyurea—brain cancer	0.000306	0.00246	CcSEcCtD
Nilutamide—Asthenia—Carmustine—brain cancer	0.000299	0.0024	CcSEcCtD
Nilutamide—Paraesthesia—Etoposide—brain cancer	0.000289	0.00232	CcSEcCtD
Nilutamide—Asthenia—Temozolomide—brain cancer	0.000289	0.00232	CcSEcCtD
Nilutamide—Dyspnoea—Etoposide—brain cancer	0.000287	0.0023	CcSEcCtD
Nilutamide—Diarrhoea—Carmustine—brain cancer	0.000285	0.00229	CcSEcCtD
Nilutamide—Pruritus—Temozolomide—brain cancer	0.000285	0.00228	CcSEcCtD
Nilutamide—Decreased appetite—Etoposide—brain cancer	0.00028	0.00225	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Etoposide—brain cancer	0.000278	0.00223	CcSEcCtD
Nilutamide—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000277	0.00644	CbGpPWpGaD
Nilutamide—Dizziness—Carmustine—brain cancer	0.000275	0.00221	CcSEcCtD
Nilutamide—Constipation—Etoposide—brain cancer	0.000275	0.00221	CcSEcCtD
Nilutamide—Pain—Etoposide—brain cancer	0.000275	0.00221	CcSEcCtD
Nilutamide—Diarrhoea—Temozolomide—brain cancer	0.000275	0.00221	CcSEcCtD
Nilutamide—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000273	0.00636	CbGpPWpGaD
Nilutamide—Dizziness—Temozolomide—brain cancer	0.000266	0.00214	CcSEcCtD
Nilutamide—Feeling abnormal—Etoposide—brain cancer	0.000265	0.00213	CcSEcCtD
Nilutamide—Vomiting—Carmustine—brain cancer	0.000265	0.00212	CcSEcCtD
Nilutamide—Gastrointestinal pain—Etoposide—brain cancer	0.000263	0.00211	CcSEcCtD
Nilutamide—Rash—Carmustine—brain cancer	0.000263	0.00211	CcSEcCtD
Nilutamide—Dermatitis—Carmustine—brain cancer	0.000262	0.0021	CcSEcCtD
Nilutamide—Headache—Carmustine—brain cancer	0.000261	0.00209	CcSEcCtD
Nilutamide—Vomiting—Temozolomide—brain cancer	0.000256	0.00205	CcSEcCtD
Nilutamide—Abdominal pain—Etoposide—brain cancer	0.000255	0.00204	CcSEcCtD
Nilutamide—Body temperature increased—Etoposide—brain cancer	0.000255	0.00204	CcSEcCtD
Nilutamide—Rash—Temozolomide—brain cancer	0.000254	0.00204	CcSEcCtD
Nilutamide—Dermatitis—Temozolomide—brain cancer	0.000254	0.00203	CcSEcCtD
Nilutamide—Headache—Temozolomide—brain cancer	0.000252	0.00202	CcSEcCtD
Nilutamide—Nausea—Carmustine—brain cancer	0.000247	0.00198	CcSEcCtD
Nilutamide—Nausea—Temozolomide—brain cancer	0.000239	0.00192	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000233	0.00543	CbGpPWpGaD
Nilutamide—Asthenia—Etoposide—brain cancer	0.000231	0.00185	CcSEcCtD
Nilutamide—Pruritus—Etoposide—brain cancer	0.000228	0.00183	CcSEcCtD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000226	0.00525	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000221	0.00515	CbGpPWpGaD
Nilutamide—Diarrhoea—Etoposide—brain cancer	0.00022	0.00177	CcSEcCtD
Nilutamide—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000219	0.00511	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000216	0.00504	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000214	0.005	CbGpPWpGaD
Nilutamide—Dizziness—Etoposide—brain cancer	0.000213	0.00171	CcSEcCtD
Nilutamide—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000205	0.00478	CbGpPWpGaD
Nilutamide—Vomiting—Etoposide—brain cancer	0.000205	0.00164	CcSEcCtD
Nilutamide—Rash—Etoposide—brain cancer	0.000203	0.00163	CcSEcCtD
Nilutamide—Dermatitis—Etoposide—brain cancer	0.000203	0.00163	CcSEcCtD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000202	0.00471	CbGpPWpGaD
Nilutamide—Headache—Etoposide—brain cancer	0.000202	0.00162	CcSEcCtD
Nilutamide—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000194	0.00453	CbGpPWpGaD
Nilutamide—Nausea—Etoposide—brain cancer	0.000191	0.00153	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000186	0.00434	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000185	0.00431	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000183	0.00427	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.000183	0.00426	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000181	0.00422	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000181	0.00422	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000181	0.00421	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000174	0.00406	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.00017	0.00397	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000154	0.00358	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000153	0.00357	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00015	0.0035	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000148	0.00345	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000147	0.00343	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000146	0.00339	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000138	0.00321	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000137	0.00319	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000135	0.00315	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000134	0.00312	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000131	0.00306	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000118	0.00275	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000117	0.00272	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.000117	0.00272	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000114	0.00265	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000107	0.00249	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000106	0.00247	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—ESR2—brain cancer	9.26e-05	0.00216	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	8.85e-05	0.00206	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NOTCH2—brain cancer	8.77e-05	0.00204	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	8.76e-05	0.00204	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.54e-05	0.00199	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.3e-05	0.00193	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.87e-05	0.00183	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	7.71e-05	0.0018	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.52e-05	0.00175	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.33e-05	0.00171	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.26e-05	0.00169	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	7.1e-05	0.00165	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.03e-05	0.00164	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	6.94e-05	0.00162	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.39e-05	0.00149	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.88e-05	0.00137	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	5.83e-05	0.00136	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.76e-05	0.00134	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.75e-05	0.00134	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.14e-05	0.0012	CbGpPWpGaD
Nilutamide—AR—Gene Expression—DNMT1—brain cancer	4.97e-05	0.00116	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.83e-05	0.00113	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.69e-05	0.00109	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ESR2—brain cancer	4.46e-05	0.00104	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH2—brain cancer	4.22e-05	0.000984	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SIRT1—brain cancer	3.59e-05	0.000837	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2C9—brain cancer	3.51e-05	0.000817	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2C9—brain cancer	3.13e-05	0.000729	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—BSG—brain cancer	2.98e-05	0.000695	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—brain cancer	2.92e-05	0.000681	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—BSG—brain cancer	2.66e-05	0.00062	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—IDH1—brain cancer	2.56e-05	0.000598	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—BSG—brain cancer	2.43e-05	0.000566	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—IDH1—brain cancer	2.29e-05	0.000533	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.09e-05	0.000487	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—IDH1—brain cancer	2.09e-05	0.000486	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ENO2—brain cancer	2.03e-05	0.000472	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.86e-05	0.000434	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ENO2—brain cancer	1.81e-05	0.000422	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.7e-05	0.000396	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ENO2—brain cancer	1.65e-05	0.000384	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—brain cancer	1.41e-05	0.000328	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CG—brain cancer	9.3e-06	0.000217	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CG—brain cancer	8.3e-06	0.000193	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CG—brain cancer	7.57e-06	0.000176	CbGpPWpGaD
